LNTH Profile
Lantheus Holdings Inc. (LNTH) is a global leader in the development, manufacture, and commercialization of diagnostic medical imaging agents and products. The company's products include contrast agents used in medical imaging procedures such as ultrasound, computed tomography (CT), and magnetic resonance imaging (MRI). These agents are used to enhance the visibility of specific organs, tissues, or blood vessels, helping to facilitate accurate diagnosis and treatment planning. Lantheus' portfolio of products includes the Definity and Lumason contrast agents for cardiovascular and liver imaging, respectively. The company is also developing new contrast agents for use in oncology, neurology, and other fields. Lantheus is headquartered in North Billerica, Massachusetts, and as of September 2021, had a market capitalization of approximately $2.2 billion.
|
